California National Primate Research Center
California National Primate Research Center
批准号:
10555821
负责人:
Simon J. Atkinson
金额:
$1185.79万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
未结题
起止时间:
1997-05-01 至 2028-04-30
关键词:
AddressAgeAgingAlzheimer&aposs DiseaseAnatomyAnimal ExperimentationAnimalsAppointmentAreaBehaviorBiological AssayBiomedical ResearchCOVID-19CaliforniaCaringClinical PathologyCollaborationsCommunicable DiseasesCommunitiesCore FacilityDedicationsDevelopmentDiseaseEducation and OutreachElderlyEnsureFlow CytometryFosteringFundingGeneticGoalsGrantGrowthHealthHealth ServicesHumanInformation TechnologyInfrastructureInhalation ExposureInstitutionKnowledgeLaboratoriesLeadLongevityMedicalMedicineMentorsMissionModelingMultimodal ImagingNational Institute on AgingNeurosciencesPreventionPrimatesQuality of lifeRegenerative MedicineReproductive SciencesResearchResearch DesignResearch PersonnelResearch PriorityResearch SupportResourcesRoleSchoolsScienceScientistServicesSiteTrainingUnited States National Institutes of HealthUniversitiesVeterinariansVisionZIKAZika Virusanimal carebasebehavioral healthbiobehaviorcareercollegefightinghigh standardhuman diseaseimprovedindustry partnernext generationnonhuman primateoperationoutreachpopulation healthprogramspsychologicrecruitresponsible research conducttooltranslational scientist
中文摘要
总体:加州州灵长类动物研究中心
摘要
位于加州大学戴维斯分校的加州国家灵长类动物研究中心(CNPRC),
要求资金在下一个五年期(2023年5月1日)延长基本运营补助金#P51-OD 011107
2028年4月30日)。目前,在第60年的运作,CNPRC提供了一系列NIH支持的
全国范围内的调查人员和行业合作伙伴。从成立到本年度,CNPRC一直
通过提供高质量的动物、设施、工具和服务,高度响应研究界的要求
由核心科学家的知识基础设施驱动,为我们的使命服务:“改善人类健康,
健康和生活质量,通过特殊的非人类灵长类动物研究计划的支持”。的
申请的补充资金符合以下具体目标:(1)进行最先进的研究,
科学上有助于理解和治疗人类疾病的非人类灵长类动物模型
(2)为研究人员提供卓越的非人灵长类专业知识和服务,
地方,地区和国家层面,以推进NIH支持的卓越研究,(3)指导和培训下一个
产生具有非人灵长类专业知识的翻译研究人员,并向公众通报
非人灵长类动物模型的重要性和翻译能力,以及(4)确保最高标准的
负责任地进行研究和动物护理。我们将继续强调团队科学,
整个生命周期的人类健康问题,目标是超越传统的跨学科努力,
真正解决研究问题。请求为行政事务提供支助
(行政和业务处、主任办公室、信息技术处)、改建和
翻修(设施改善),菌落管理股(解剖和临床病理学服务,
动物护理和研究服务,生物行为评估,遗传学管理服务
老龄群体研究所、人口与行为健康服务和灵长类医学服务),服务
核心(流式细胞术、吸入暴露、多模式成像、灵长类动物试验实验室),科学
研究单位(呼吸系统疾病,传染病,神经科学和行为,
生殖科学和再生医学)、外联/公共信息办公室和试点研究
程序.我们致力于开发和提供广泛的研究机会,
使用非人类灵长类动物模型来改善人类健康。加州大学戴维斯分校的机构承诺,
CNPRC是杰出的,并将继续促进我们在将非人灵长类动物研究纳入
转化生物医学研究的下一个时代。
英文摘要
OVERALL: CALIFORNIA NATIONAL PRIMATE RESEARCH CENTER
ABSTRACT
The California National Primate Research Center (CNPRC), located at the University of California, Davis,
requests funds to renew the base operating grant #P51-OD011107 for the next five-year period (May 1, 2023
through April 30, 2028). Currently in the 60th year of operation, the CNPRC serves a range of NIH-supported
investigators and industry partners nationwide. From inception through the current year, the CNPRC has been
highly responsive to the research community by providing high quality animals, facilities, tools, and services
driven by the intellectual infrastructure of the Core Scientists in the service of our Mission: “To improve human
health and quality of life through support of exceptional nonhuman primate research programs”. The
supplemental funds requested fits within the following Specific Aims: (1) Conduct state-of-the-art research and
scientifically contribute to the understanding and treatment of human disease with nonhuman primate models
across the life span, (2) Provide exceptional nonhuman primate expertise and services to investigators at the
local, regional, and national levels to advance NIH-supported research excellence, (3) Mentor and train the next
generation of translational investigators with nonhuman primate expertise and inform the public regarding the
importance and translational power of the nonhuman primate model, and (4) Ensure the highest standards of
responsible conduct of research and animal care. We will continue to emphasize team science aimed at major
human health problems across the lifespan, with the goal of moving beyond traditional interdisciplinary efforts to
true convergence on the research problems being addressed. Support is requested for Administrative Services
(Administration and Operations Services, Director’s Office, Information Technology Services), Alterations and
Renovations (Facilities Improvement), Colony Management Unit (Anatomic and Clinical Pathology Services,
Animal Care and Research Services, BioBehavioral Assessment, Genetics Management Services National
Institute on Aging Colony, Population and Behavioral Health Services, and Primate Medicine Services), Service
Cores (Flow Cytometry, Inhalation Exposure, Multimodal Imaging, Primate Assay Laboratory), Scientific
Research Units (Cardiorespiratory Diseases, Infectious Diseases, Neuroscience and Behavior, and
Reproductive Sciences and Regenerative Medicine), Outreach/Public Information Office, and the Pilot Research
Program. We are committed to developing and providing a wide range of research opportunities that maximize
use of the nonhuman primate model to improve human health. The institutional commitment from UC Davis to
the CNPRC is outstanding and will continue to facilitate our role in moving nonhuman primate research into the
next era of translational biomedical research.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8107323
-
项目类别:
-
资助金额:$38.5万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8470639
-
项目类别:
-
资助金额:$32.32万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8675226
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Utilizing siRNA to Minimize Nephrotoxic Injury
-
批准号:8318626
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2011
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7990218
-
项目类别:
-
资助金额:$6.42万
-
财政年份:2009
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:8069200
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7899725
-
项目类别:
-
资助金额:$31.86万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:8274881
-
项目类别:
-
资助金额:$31.54万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7382355
-
项目类别:
-
资助金额:$31.66万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7856981
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2008
-
负责人:Simon J. Atkinson
-
依托单位:
Rac2 in reglation of cytoskeletal function
-
批准号:6595711
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2002
-
负责人:Simon J. Atkinson
-
依托单位:
Core--Imaging
-
批准号:6595717
-
项目类别:
-
资助金额:$21.74万
-
财政年份:2002
-
负责人:Simon J. Atkinson
-
依托单位:
Rho GTPases and Actin Cytoskeletal Function in Renal Ischemia
-
批准号:7409893
-
项目类别:
-
资助金额:$36.54万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6177991
-
项目类别:
-
资助金额:$21.05万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6617845
-
项目类别:
-
资助金额:$23.0万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6523695
-
项目类别:
-
资助金额:$22.33万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:6381050
-
项目类别:
-
资助金额:$21.68万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
RHO GTPASES AND ACTIN FUNCTION IN RENAL ISCHEMIA
-
批准号:2908123
-
项目类别:
-
资助金额:$20.5万
-
财政年份:1999
-
负责人:Simon J. Atkinson
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
芹菜素通过AGE-RAGE通路抑制干眼的炎症与氧化应激
-
批准号:82505677
-
项目类别:青年科学基金项目(C类)
-
资助金额:30.00万元
-
批准年份:2025
-
负责人:吕雨霏
-
依托单位:
麝香通心滴丸通过干预AGE-RAGE轴调节O-GlcNAc修饰发挥防治DCM作用的药效物质及机制研究
-
批准号:82574874
-
项目类别:面上项目
-
资助金额:49.00万元
-
批准年份:2025
-
负责人:刘天华
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位: